Folium Biosciences is an established supplier of Active Pharmaceutical Ingredients for therapeutic product development. Our team of experts has been conducting clinical research in cannabinoids since the start of the industry, which means that we understand precisely what a pharmaceutical company needs to have when it comes to securing approvals from global ethical commissions regulatory bodies. To date, our CBD API has been adopted for pharmaceutical formulations in countries including Australia, New Zealand, and South America.